Skip to main content
  • Wegovy Pill Crosses 3 Million Prescriptions in Just Five Months: Novo Nordisk's Obesity Bet Pays Off

    Oral GLP-1 therapy is bringing obesity treatment to millions of patients who had never used weight-loss medicines before

    The obesity treatment landscape is changing at remarkable speed, and Novo Nordisk has just added another milestone to the story.

    The Danish pharmaceutical giant announced that Wegovy® (semaglutide) tablets 25 mg have surpassed 3 million prescriptions in the United States within just over five months of launch, making it one of the strongest pharmaceutical product launches by prescription volume in recent U.S. history.

  • Europe’s Pharma Investment Challenge : Why Global Drugmakers Are Reconsidering Germany and the UK

    Billions in Planned Investments Are Being Delayed, Reduced, or Redirected as Pharmaceutical Companies Reassess Europe’s Competitiveness.

    For decades, Europe has been one of the world's leading destinations for pharmaceutical research, manufacturing, and innovation. Germany has long been regarded as the manufacturing powerhouse of the European pharmaceutical industry, while the United Kingdom has served as a global center for life sciences research and drug development.

  • Can Photodynamic Therapy Help Eliminate HPV? Mexican Study Draws Global Attention

    Human Papillomavirus (HPV) remains one of the most common viral infections worldwide and is strongly associated with cervical cancer. While preventive HPV vaccines have transformed public health strategies, effective treatment options for existing HPV infections and precancerous cervical lesions continue to be an active area of research.

  • Hingot (Balanites aegyptiaca) : Phytochemical and Pharmacological Advances

    HarshAbout Authors
    Harsh Bhardwaj1, Muskan Baller2, Rupali Dilip Taru3, Raaz K Maheshwari4

  • Pharmacological Potential of Dragon Fruit (Selenicereus spp.)

    HarshAbout Authors
    Harsh Bardwaj1*, Monika CHamoli2, Raaz K Maheshwari3
    Assistant Professor, Department of Chemistry, Shri Ratanlal Kanwarlal Patni Girls’ College, Kishangarh, Ajmer, Rajasthan, India

  • Dietary Nitrate of Beetroot Juice : Clinical Evidence, Biological Mechanism, and New Applications

    HarshHarsh Bhardwaj1*, Sakshi Jain2, Raaz K Maheshwari3
    1Assistant Professor, Department of Chemistry, Shri RK Patni Girls’ College, Kishangarh, Ajmer, Rajasthan, India

  • How India Reduced the Cost of Cataract Lenses and Restored Millions of Eyesight

    In the 1970s, India was facing a silent epidemic of cataract blindness. Millions of elderly people were losing their eyesight, not because treatment was unavailable, but because it was unaffordable. Cataract surgery required replacing the cloudy natural lens with a clear artificial intraocular lens (IOL). At that time, these lenses were imported and cost nearly 100 US dollars each, far beyond the reach of poor patients.

    At the center of the solution was a remarkable man, Dr. Govindappa Venkataswamy, lovingly known as Dr. V.

  • When Pills Talk Back: Inside MIT’s Swallowable Technology That Could Transform Medication Adherence
    For decades, one of medicines most stubborn challenges hasnt been discovering new drugs, its making sure patients actually take them. Missed doses, delayed schedules, and incomplete treatments quietly undermine even the most advanced therapies, contributing to hundreds of thousands of preventable deaths and billions of dollars in healthcare costs every year.
  • Pharmaceutical acquisition and mergers of 2025

    The year 2025 marked a strong revival in pharmaceutical mergers and acquisitions, as global drug makers moved firmly to strengthen pipelines, manage upcoming patent expiries, and secure sustainable growth. Several high-value and strategically important deals defined the year, reflecting renewed confidence in the sector. Major pharmaceutical companies pursued acquisitions not just for scale, but for access to late-stage assets, innovative technologies, and high-growth therapeutic areas.

  • Kopulan Strips-for Sublingual Administration of Active

    Vinay KumarVinay Kumar Singh. 
    Head-Formulation
    Kumar Organic Products Research Centre Pvt. Ltd.,
    Bengaluru
    Email : formulation_krc@kopresearchcentre.net

Subscribe to Articles